newsfilter
← Latest News
ACCESS Newswire·

Apollo Endosurgery Announces Preliminary Third Quarter 2021 Financial Results and Provides Business Updates

Revenue expected between $16.0 million and $16.4 million Third consecutive quarter of double-digit revenue growth; endoscopic suturing up over 30% Submitted a De Novo 510(k) Classification Request to FDA for Apollo ESG™ for weight loss and Apollo RE